Navigation Links
Data from Phase 2 Study of Alder Biopharmaceuticals' Anti-IL-6 Antibody Therapeutic, ALD518, Demonstrate Reversal of Anemia in Patients with Advanced Non-Small Cell Lung Cancer
Date:12/7/2010

ORLANDO, Fla., Dec. 7, 2010 /PRNewswire/ -- Alder Biopharmaceuticals Inc. today announced that data from a Phase 2 study of its ALD518 investigational antibody therapeutic that targets interleukin-6 (IL-6) demonstrate a reversal of anemia in patients with advanced non-small cell lung cancer (NSCLC).

After 12 weeks of treatment with the anti-inflammatory therapeutic, 58 percent of patients who received ALD518 experienced hemoglobin level increases from less than 11 g/dL to more than 12 g/dL, while no patients receiving placebo experienced this increase. In addition, patients who received ALD518 had an average lean body mass loss of 0.19 kg, compared to an average loss of 1.5 kg in those who received placebo. Additional symptoms of the disease such as fatigue were also reduced in patients who received ALD518.

The data was presented by Michael Schuster, M.D., director of the hematologic malignancy program at Stony Brook University Medical Center, at the annual meeting of the American Society of Hematology. The presentation, titled "Inhibition of Interleukin-6 (IL-6) Reverses Anemia In Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Trial," took place on Monday, December 6.

"The anemia of chronic disease that is seen in cancer patients is in large part due to IL-6 stimulation of hepcidin, resulting in reduced plasma iron levels," said Dr. Schuster. "Given the recent safety concerns over the use of ESAs, alternative therapeutic approaches that target IL-6, such as ALD518, would be very desirable and could potentially reduce the requirement for transfusions in this patient population."

Randall Schatzman, Ph.D., president and chief executive officer of Alder Biopharmaceuticals, added, "We continue to be encouraged by strong clinical data from ALD518 in the areas of cancer, cancer supportive care and cancer anemia. We look forward to continuing our clinical investig
'/>"/>

SOURCE Alder Biopharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014  Columbia Laboratories, Inc. ... a provider of pharmaceutical development, clinical trial manufacturing, and ... today announced that it will participate at the upcoming ... Conference, to be held in New York ... at 11:15am on September 9, 2014 at the New ...
(Date:8/27/2014)... NORWALK, Conn. , Aug. 27, 2014  UBM ... , a leading online community for medical imaging professionals, ... Association for Medical Imaging Management,s 2014 Annual Meeting ... the conference coverage: , 11 Principles ... management can lead to greater profitability. , ...
(Date:8/27/2014)... , Aug. 27, 2014 Ambit Biosciences (Nasdaq: ... development of drugs targeting unmet needs in oncology, autoimmune and ... 2014 Health Care Conference to be held at The New ... on September 3-4, 2014. Alan Fuhrman ... and its lead drug candidate, quizartinib, at 1:10 p.m. ET ...
Breaking Medicine Technology:Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 2Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 3Ambit Announces Participation At Baird 2014 Health Care Conference 2
... 23, 2011 Arctic Ease is proud to announce that ... Team Arctic Ease®.  Davis will serve as a face of ... introduce Arctic Ease® to millions of sports fans across the ... of cold therapy that are odorless, menthol free and do ...
... (Nasdaq: ROCM ) announced today that Roger W. ... conclusion of the Company,s 2012 Annual Meeting of Shareholders to ... of his current term. Board Chairman and CEO ... our Board since 1995.  His cheerful intelligence and gracious temperament ...
Cached Medicine Technology:Vernon Davis Joins Team Arctic Ease® as Spokesperson for Arctic Ease® Cryotherapy Wraps and Pads 2Vernon Davis Joins Team Arctic Ease® as Spokesperson for Arctic Ease® Cryotherapy Wraps and Pads 3Rochester Medical Director Schnobrich to Retire 2
(Date:8/27/2014)... BRIC Laparoscopes Market Outlook to 2020 ... market data on the BRIC Laparoscopes market. The report ... units) and average prices (in US dollars) within market ... Tip Video Laparoscopes), Robotic Surgical Systems and Rigid Tip ... to the patient with laparoscopic surgery versus the more ...
(Date:8/27/2014)... Sound Telecom, a leading telecommunications company that ... communication systems, has unveiled an article titled “ Three ... Messaging .” The piece examines the world of medical ... remain compliant with HIPAA and HITECH requirements. , ... at Sound Telecom, opens with evidence that the use ...
(Date:8/27/2014)... York, New York (PRWEB) August 27, 2014 ... hip lawsuits ( http://www.consumerinjurylawyers.com/DePuy/ ) has extended the deadline ... According to an August 2014 Order issued by U.S. ... Ohio, those wishing to enroll in the DePuy ASR ... (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products ...
(Date:8/27/2014)... York (PRWEB) August 27, 2014 As ... society today, big business has taken notice. With 23 ... of medical cannabis friendly legislation on their books the ... states such as New York and Florida are in ... medical marijuana laws a void of reliable information and ...
(Date:8/27/2014)... WEDNESDAY, Aug. 27, 2014 (HealthDay News) -- There,s been ... antidepressants by women during their pregnancies might raise the ... Now, a study involving more than 13,000 children finds ... children whose mothers used an antidepressant while pregnant, but ... (ADHD) in these youngsters. The findings challenge prior ...
Breaking Medicine News(10 mins):Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 2Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 3Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 4Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 2Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 3Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 2Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 3Health News:The Marijuana Real Estate Market Opens Up 2Health News:The Marijuana Real Estate Market Opens Up 3Health News:Do Antidepressants in Pregnancy Raise Risks for Mental Woes in Kids? 2Health News:Do Antidepressants in Pregnancy Raise Risks for Mental Woes in Kids? 3
... of bacteria found in soil boosts happiness levels and could ... and prone to infection, says a study. ,British ... cancer patients with the bacteria, named 'bacterium Mycobacterium vaccae', and ... edition of BBC News. ,However, they said ...
... our stomach may reduce the protective effects of antioxidants ... Glasgow found that in the presence of lipid the ... component of vitamin C), to protect against the generation ... than when no lipids are present. “Our results illustrate ...
... doctors attempting to conduct tests on Mt Everest,// the highest peak ... Nepal government said the research was illegal. ,The ... University College London had announced in 2005 that it would lead ... the amount of oxygen in their own blood on the summit ...
... reports of stray dogs in metropolitan cities killing small children ... out protests from hundreds of animal lovers. // ,Recently ... stray dogs in Hyderabad. Authorities had caught about 22,000 ... Bangalore has led to an uproar with animal rights activists ...
... you are looking for the perfect partner in life, forget ... // ,Researchers at Manchester University in northern Britain said ... concluded that the zodiac had no impact on chances of ... were released Monday. ,The investigation used census data ...
... celebrate the silver jubilee of The Art of Living in ... free' America initiative;// is being launched by Indian spiritual guru ... to be attended by over 2,500 people along with 20 ... to foster human values such as compassion, friendliness, a sense ...
Cached Medicine News:Health News:Animal Lovers Protest Brutal Dog Killings 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: